Volume 119, Issue 3 , Pages 687-696, March 2007
TNF polymorphism and bronchoalveolar lavage cell TNF-α levels in chronic beryllium disease and beryllium sensitization
Background
Beryllium stimulates TNF-α from chronic beryllium disease (CBD) bronchoalveolar lavage (BAL) cells.
Objective
We sought to relate TNF polymorphisms to beryllium-stimulated TNF-α production, to the development of CBD, and to the risk of more severe CBD over time.
Methods
We recruited 147 patients with CBD, 112 beryllium-sensitized subjects, and 323 control subjects; genotyped 5 TNF promoter polymorphisms; and measured beryllium-stimulated and unstimulated BAL cell TNF-α production from a subset of subjects.
Results
Beryllium-stimulated, but not beryllium-unstimulated, BAL cell TNF-α production was significantly increased in patients with CBD compared with that seen in those only sensitized (P = .0002). Those subjects with the TNF –857T allele and the only haplotype (haplotype 4) containing this allele demonstrated significantly lower unstimulated BAL cell TNF-α production compared with that seen in noncarriers (P = .009). Patients with CBD alone and combined with sensitized subjects carrying the TNF haplotype 1 compared with those without this haplotype had significantly increased beryllium-stimulated BAL cell TNF-α levels (P = .02). We found no significant association between patients with CBD, sensitized subjects, and control subjects with any of the TNF promoter polymorphisms or haplotypes. A greater decrease in Pao2 at maximum exercise was noted in patients with CBD with the −1031C allele (P = .03) and with haplotypes other than the TNF haplotype 1 (P = .01), 3 (from 5) of which contain the −1031C allele.
Conclusions
The −857T allele and haplotype 1 are associated with BAL cell TNF-α production, indicating a potential role of TNF promoter variants in regulation of TNF production in sensitized subjects and patients with CBD.
Clinical implications
TNF promoter variants are not risk factors for CBD or sensitization.
Key words: TNF-α, chronic beryllium disease, beryllium sensitization, berylliosis, genetics, polymorphism, bronchoalveolar lavage
Abbreviations used: BAL, Bronchoalveolar lavage, Be, Beryllium, BeLPT, Beryllium lymphocyte proliferation test, BeS, Beryllium sensitized, CBD, Chronic beryllium disease, NF, Nuclear factor, Pao2m, Pao2 at maximal exercise, SNP, Single nucleotide polymorphism
Supported by P01 ES11810 and M01 RR00051 from the National Institutes of Health.Disclosure of potential conflict of interest: L. A. Maier has received grant support from Centocor and has served as an expert witness on behalf of her patients with CBD, for which she did not receive any direct compensation. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(06)02296-2
doi:10.1016/j.jaci.2006.10.028
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 119, Issue 3 , Pages 687-696, March 2007
